The US government won't even allow drug re-importation, and you think it's gonna take over hospitals and run them differently?
-
-
Replying to @peroxycarbonate @primalpoly
this is a helpful dialogue. not a health care economist so can't fully endorse but seems good https://origin-www.bloombergview.com/articles/2016-01-22/health-care-s-continental-divide …
1 reply 0 retweets 0 likes -
Replying to @eigenrobot @primalpoly
Half of US healthcare spending already goes through the government - that's more than many countries spend.
1 reply 0 retweets 1 like -
Replying to @peroxycarbonate @primalpoly
On the other hand, Megan's argument in that article about lower costs reducing innovation...seems false.
1 reply 0 retweets 0 likes -
Replying to @peroxycarbonate @primalpoly
Consider that US hospitals cost 2x as much per bed as UK ones.
1 reply 0 retweets 0 likes -
Replying to @peroxycarbonate @primalpoly
Consider that US hospitals have been buying private practices because hospitals can get higher rates for stuff.
1 reply 0 retweets 1 like -
Replying to @peroxycarbonate @primalpoly
v interesting. y we're probably getting zero efficiency innovations (at best) but iirc her point was re: pharma innov?
1 reply 0 retweets 0 likes -
Replying to @eigenrobot @primalpoly
Half the drugs being prescribed now aren't actually helping people.
1 reply 0 retweets 0 likes -
Replying to @peroxycarbonate @primalpoly
When trials started being run better suddenly the drug pipeline dried up.
2 replies 0 retweets 1 like -
Replying to @peroxycarbonate @primalpoly
For example, the 1997 FDAMA required pre-registration of clinical trials to prevent cherry picking good ones.
1 reply 0 retweets 1 like
interesting this is leading me to theory that there are frequent innovations in US market, just in fleecing technology
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.